Endometrial cancer is the most common gynaecological cancer in many parts of India and rising rapidly. The single strongest modifiable risk factor is obesity — and India’s obesity prevalence has roughly doubled in two decades. This article explains the biology, the numbers, and what can be done.
On this page
- Why obesity drives endometrial cancer
- How much risk is added
- PCOS, diabetes — multipliers
- Symptoms in higher-risk women
- Prevention and screening
Endometrial cancer obesity link — Why obesity drives endometrial cancer
Adipose tissue (body fat) is hormonally active. It converts androgens to estrogens via aromatase enzyme. In post-menopausal women, this peripheral estrogen production is the dominant source — and unopposed estrogen (without progesterone balance) stimulates endometrial growth. Over years, this can lead to endometrial hyperplasia and then cancer.
How much risk does obesity add?
- BMI 25–30 (overweight): risk roughly doubled vs normal weight
- BMI 30–35 (obese): risk approximately 3-fold
- BMI 35-40 (severely obese): risk approximately 5–6 fold
- BMI > 40 (morbidly obese): risk 8–10 fold
For Indian women, ethnicity-specific BMI cut-offs apply (overweight at BMI 23, obese at 25) because of higher body-fat composition at same BMI.
PCOS, diabetes — multipliers
Polycystic Ovary Syndrome (PCOS) causes anovulation, prolonged unopposed estrogen exposure, and is associated with insulin resistance — all of which compound endometrial cancer risk. Long-standing PCOS in obese women carries among the highest endometrial cancer risks in the gynaecological literature.
Diabetes (Type 2) is an independent risk factor through insulin-IGF-1 signalling pathways that promote endometrial cell proliferation. The combination of obesity + diabetes + PCOS is particularly concerning.
Symptoms higher-risk women should not ignore
- Any post-menopausal bleeding (90% sensitive for endometrial cancer)
- Irregular or heavy periods becoming heavier in your 40s
- Bleeding between periods
- Watery or blood-tinged vaginal discharge
See our dedicated post: postmenopausal bleeding evaluation.
Prevention and surveillance
The single most effective preventive intervention is weight management. Even 5–10% body weight reduction lowers endometrial cancer risk measurably. For women with PCOS, hormonal management (progestin-containing contraception or LNG-IUD) protects the endometrium from unopposed estrogen.
Population-wide endometrial cancer screening is not currently recommended. However, women with risk factors (obesity + PCOS + diabetes + family history) should report any abnormal bleeding promptly. Surveillance protocols are individualised.
For full disease overview see endometrial cancer page and stage-specific treatment: Stage 1, fertility-sparing options.
FAQs
Does losing weight reverse the risk?
Risk decreases progressively with sustained weight loss. The longer you remain at a healthier weight, the lower the lifetime risk.
I have PCOS but normal weight. Am I still at risk?
Modest elevation in risk from PCOS itself, primarily driven by anovulation. Hormonal management can mitigate it. Discuss with your gynaecologist.
Should I have endometrial biopsy as screening if I'm obese?
Not routinely. Reserved for women with abnormal bleeding, thickened endometrium on ultrasound, or specific high-risk genetic syndromes.
Is bariatric surgery preventive?
Significant data shows bariatric surgery reduces endometrial cancer incidence in severely obese women, partly through weight loss and partly through hormonal changes.
What about HRT?
Estrogen-only HRT increases endometrial cancer risk in women with intact uteruses. Combined estrogen-progestogen HRT is protective. This is why HRT prescribing must always consider uterine status.
Consultation and Next Steps
For an individualised consultation on endometrial cancer obesity link, share your reports on WhatsApp at +91 76988 00333. Dr. Nishtha Tripathi Patel provides a detailed assessment within 24-48 hours and arranges in-person consultation at Sterling Hospitals, KD Hospital, or Welcare Speciality Hospital in Ahmedabad based on your location and treatment requirements.
Bring the following to your first consultation: imaging studies (ultrasound, CT or MRI on CD), histopathology and biopsy reports, tumour marker results (CA-125, HE4, CEA where relevant), a list of current medications, and any prior treatment summaries. For patients travelling from outside Ahmedabad, scheduling can be arranged to complete consultation and any pre-op work-up in the fewest possible visits.
If you are exploring second-opinion options, see our second-opinion service page. Independent review of diagnosis, staging, and proposed treatment plans is provided at no cost via WhatsApp report review. You do not need to switch hospitals to obtain a second opinion.
For broader information about endometrial cancer obesity link and related conditions, also see our complete ovarian cancer guide, HIPEC India guide, cervical cancer guide and robotic surgery guide.
Reviewed by Dr. Nishtha Tripathi Patel, MBBS, DGO, DNB, Fellowship Gynaecological Oncology, ESGO-certified. To book: WhatsApp +91 76988 00333.